atenolol has been researched along with lisinopril in 73 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (5.48) | 18.7374 |
1990's | 20 (27.40) | 18.2507 |
2000's | 19 (26.03) | 29.6817 |
2010's | 29 (39.73) | 24.3611 |
2020's | 1 (1.37) | 2.80 |
Authors | Studies |
---|---|
Funakoshi, J; Kakumoto, M; Okumura, K; Sakaeda, T; Takara, K; Tanigawara, Y | 1 |
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Campillo, NE; Guerra, A; Páez, JA | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
Avdeef, A; Tam, KY | 1 |
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Bellera, CL; Bruno-Blanch, LE; Castro, EA; Duchowicz, PR; Goodarzi, M; Ortiz, EV; Pesce, G; Talevi, A | 1 |
Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Brunner, HR; Hayoz, D; Meister, JJ; Perret, F; Tardy, Y; Waeber, B | 1 |
Gerlin-Piira, L; Hämäläinen, K; Kyllönen, E; Kyllönen, T; Lonka, R; Parviainen, R; Selonen, R; Soininen, K; Suihkonen, J; Tikkanen, T | 1 |
Hedner, T; Herlitz, H; Ljungman, S; Pennert, K; Samuelsson, O; Widgren, B | 1 |
Huttunen, M; Ikäheimo, M; Kontro, J; Lampainen, E; Lilja, M; Mäkynen, P; Savolainen, A | 1 |
Boucher, CA; Christensen, DM; Higgins, J; Zusman, RM | 1 |
Darne, B; Fouchard, M; Garabedian, VG; Madonna, O; Pannier, BE; Safar, ME | 1 |
Admani, K; Angell-James, JE; Beevers, DG; Blackwood, RA; Feely, M; Garnham, S; Husaini, MH; Kumar, S; Mehrzad, AA; Watson, M | 1 |
Arriaga, J; Bernal, R; Bernardes, H; Bolzano, K; Calderon, JL; Debruyn, J; Dienstl, F; Drayer, J; Goodfriend, TL; Gross, W | 1 |
Cheung, DG; Graettinger, WF; Klein, RC; Lipson, JL; Weber, MA | 1 |
Goodman, C; Radford, HM; Rogers, GG; Rosendorff, C | 1 |
Parag, KB; Seedat, YK | 1 |
Fogari, R; Malamani, GD; Marasi, G; Vanasia, A; Villa, G; Zoppi, A | 1 |
Attwood, S; Bird, R; Burch, K; Casadei, B; Coats, A; Conway, J; Dawes, M; Ebbs, D; Farmer, A; Robinson, J | 1 |
Gall, MA; Nielsen, FS; Parving, HH; Rossing, P; Skøtt, P; Smidt, UM | 2 |
Amado, P; Araújo, V; Carmona, J; Castanheira, J; Nazaré, J | 1 |
Bakris, GL; Sadler, R; Slataper, R; Vicknair, N | 1 |
Antonios, TF; Cappuccio, FP; MacGregor, GA; Markandu, ND; Sagnella, GA | 1 |
Hedner, T; Lind, H; Lindholm, L; Rangemark, C; Samuelsson, O | 1 |
de Leeuw, PW; Notter, T; Zilles, P | 1 |
Chen, JW; Gall, MA; Nielsen, FS; Parving, HH; Rossing, P; Sato, A; Smidt, UM | 1 |
Corradi, L; Fogari, R; Lusardi, P; Mugellini, A; Poletti, L; Zoppi, A | 1 |
Keteyian, SJ; Levine, AB; Levine, TB; Narins, B | 1 |
Lee, TH | 1 |
Julve, R; Miralles, A; Pascual, JM; Redon, J; Rovira, E | 1 |
Faller, J; Hess, B | 1 |
Carabello, BA; De Freitas, G; Hamawaki, M; Nemoto, S | 1 |
Gao, L; Kern, TS; Widness, M; Xi, X; Zhang, JZ | 1 |
Grant, RW; Meigs, JB; Singer, DE | 1 |
Colon, P; Crow, R; Cutler, JA; Davis, BR; Dunn, K; Ellsworth, A; Franklin, S; Furberg, C; Goff, D; Golden, J; Leenen, F; Mohiuddin, S; Papademetriou, V; Piller, LB; Proschan, M | 1 |
Christian, R; Colon, PJ; Cushman, WC; Einhorn, PT; Ford, CE; Goff, DC; Henriquez, MA; Margolis, KL; Piller, LB; Vidt, DG; Wong, ND; Wright, JT | 1 |
Kumar, V; Shah, RP; Singh, S | 1 |
Fedulenkova, LV; Komissarenko, IA; Lazebnik, LB; Mikheeva, OM; Toporkov, AS; Vasnev, OS | 1 |
Christie, IC; Jennings, JR; Meltzer, CC; Muldoon, MF; Price, J | 1 |
Kumar, V; Malik, S; Singh, S | 1 |
Jennings, JR; Meltzer, CC; Muldoon, MF; Price, J; Scanlon, J; Whyte, EM | 1 |
Bestwick, JP; Law, M; Mills, S; Morris, JK; Wald, DS; Wald, NJ | 1 |
Christie, IC; Jennings, JR; Meltzer, CC; Muldoon, MF; Price, JC; Ryan, CM | 1 |
Adhikary, SD; Babu, SK; Korula, G; Ramachandran, A; Vedantam, R; Velayutham, PK | 1 |
Billot, L; Bompoint, S; Bots, ML; Cidambi, R; Field, J; Grobbee, DE; Patel, A; Poulter, N; Prabhakaran, D; Reddy, KS; Rodgers, A; Stanton, A; Thom, S | 1 |
Abraham, TN; Agarwal, R; Pappas, MK; Sinha, AD; Tegegne, GG | 1 |
Mallamaci, F; Zoccali, C | 1 |
Billot, L; Bompoint, S; Brown, A; Burch, C; Burke, H; Cass, A; Hayman, N; Hillis, GS; Jan, S; Molanus, B; Neal, B; Patel, A; Peiris, D; Rafter, N; Reid, CM; Rodgers, A; Shiel, L; Togni, S; Tonkin, A; Usherwood, T; Webster, R | 1 |
Jeffers, BW; Wang, JG; Yan, P | 1 |
Arroll, B; Bramley, D; Bryant, L; Bullen, C; Crengle, S; Doughty, RN; Elley, CR; Harwood, M; Jackson, R; Milne, RJ; Parag, V; Rafter, N; Rodgers, A; Selak, V; Wadham, A | 1 |
Beutler, D; Bosak, A; Graeme, K; Heise, CW; Loli, A; Orme, G | 1 |
Chirinos, JA; Townsend, RR | 1 |
Agarwal, R; Georgianos, PI | 3 |
Li, PK; Szeto, CC | 1 |
Amjad-Iranagh, S; Goharpey, F; Modarress, H; Yousefpour, A | 2 |
Agarwal, R | 1 |
Bots, ML; Grobbee, DE; Lafeber, M; Patel, A; Prabhakaran, D; Rodgers, A; Spiering, W; Stanton, A; Thom, S; Visseren, FL; Webster, R | 1 |
Beach, JL; Davis, BR; Ishak, A; Juraschek, SP; Mukamal, KJ; Shmerling, RH; Simpson, LM | 1 |
3 review(s) available for atenolol and lisinopril
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Effects of amlodipine and other classes of antihypertensive drugs on long-term blood pressure variability: evidence from randomized controlled trials.
Topics: Amlodipine; Antihypertensive Agents; Atenolol; Blood Pressure; Cardiovascular Diseases; Chlorthalidone; Enalapril; Humans; Hypertension; Lisinopril; Losartan; Randomized Controlled Trials as Topic | 2014 |
Systolic and diastolic hypertension among patients on hemodialysis: Musings on volume overload, arterial stiffness, and erythropoietin.
Topics: Atenolol; Diastole; Epoetin Alfa; Erythropoietin; Female; Follow-Up Studies; Humans; Hypertension; Incidence; Kidney Failure, Chronic; Lisinopril; Male; Renal Dialysis; Risk Assessment; Systole; Vascular Stiffness; Water-Electrolyte Imbalance | 2019 |
38 trial(s) available for atenolol and lisinopril
Article | Year |
---|---|
Non-invasive determination of arterial diameter and distensibility by echo-tracking techniques in hypertension.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Animals; Arteries; Atenolol; Blood Pressure; Captopril; Compliance; Dipeptides; Double-Blind Method; Humans; Hydralazine; Hypertension; Lisinopril; Nitrendipine; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Ultrasonography | 1992 |
A study of the effects of lisinopril when used in addition to atenolol.
Topics: Adolescent; Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Atenolol; Blood Pressure; Dipeptides; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Heart Rate; Humans; Hypertension; Lisinopril; Middle Aged; Time Factors | 1992 |
A comparative study of lisinopril and atenolol on low degree urinary albumin excretion, renal function and haemodynamics in uncomplicated, primary hypertension.
Topics: Adult; Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atenolol; Blood Pressure; Dipeptides; Double-Blind Method; Female; Hemodynamics; Humans; Hypertension; Kidney; Lisinopril; Male; Middle Aged | 1992 |
Which anti-hypertensive to add to a beta-blocker: ACE inhibitor or diuretic?
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atenolol; Blood Pressure; Diuretics; Drug Therapy, Combination; Enalapril; Female; Heart Rate; Humans; Hydrochlorothiazide; Lisinopril; Male; Middle Aged | 1992 |
Lisinopril versus atenolol: decrease in systolic versus diastolic blood pressure with converting enzyme inhibition.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atenolol; Blood Pressure; Double-Blind Method; Enalapril; Humans; Hypertension; Lisinopril; Male; Middle Aged | 1991 |
Lisinopril combined with atenolol in the treatment of hypertension. Swedish Lisinopril Study Group.
Topics: Adolescent; Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Atenolol; Blood Pressure; Double-Blind Method; Electrocardiography; Enalapril; Female; Humans; Hypertension; Lisinopril; Male; Middle Aged; Sweden | 1991 |
Comparison of lisinopril versus atenolol for mild to moderate essential hypertension.
Topics: Antihypertensive Agents; Atenolol; Double-Blind Method; Enalapril; Female; Humans; Hypertension; Lisinopril; Male; Middle Aged | 1991 |
The antihypertensive effect of lisinopril compared to atenolol in patients with mild to moderate hypertension.
Topics: Angiotensin-Converting Enzyme Inhibitors; Atenolol; Clinical Trials as Topic; Double-Blind Method; Enalapril; Female; Humans; Hypertension; Lisinopril; Male; Middle Aged; Random Allocation | 1987 |
Effects of angiotensin converting enzyme inhibition and beta-blockade on exercise responses in hypertensive patients.
Topics: Atenolol; Enalapril; Exercise Therapy; Hemodynamics; Humans; Hypertension; Lisinopril; Oxygen; Time Factors | 1988 |
A comparison of lisinopril and atenolol in black and Indian patients with mild-to-moderate essential hypertension.
Topics: Angiotensin-Converting Enzyme Inhibitors; Atenolol; Black People; Blood Pressure; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Enalapril; Female; Humans; Hydrochlorothiazide; Hypertension; India; Lisinopril; Male; Random Allocation; South Africa | 1987 |
Effects of different antihypertensive drugs on plasma fibrinogen in hypertensive patients.
Topics: Adolescent; Adult; Aged; Amlodipine; Antihypertensive Agents; Atenolol; Blood Glucose; Blood Pressure; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Creatinine; Fibrinogen; Heart Rate; Humans; Hydrochlorothiazide; Hypertension; Lisinopril; Male; Middle Aged; Potassium; Triglycerides; Uric Acid | 1995 |
Within-patient correlation between the antihypertensive effects of atenolol, lisinopril and nifedipine.
Topics: Adolescent; Adult; Age Factors; Aged; Atenolol; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Cross-Over Studies; Female; Humans; Hypertension; Lisinopril; Male; Middle Aged; Nifedipine; Renin | 1994 |
Impact of lisinopril and atenolol on kidney function in hypertensive NIDDM subjects with diabetic nephropathy.
Topics: Albuminuria; Apolipoproteins; Apoprotein(a); Atenolol; Blood Pressure; Circadian Rhythm; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Double-Blind Method; Female; Follow-Up Studies; Glomerular Filtration Rate; Humans; Hypertension; Kidney; Lipoprotein(a); Lisinopril; Male; Middle Aged; Potassium; Renin; Serum Albumin; Sodium; Time Factors; Triglycerides | 1994 |
Comparative effects of different antihypertensive treatments on progression of diabetic renal disease.
Topics: Albuminuria; Antihypertensive Agents; Atenolol; Diabetic Nephropathies; Diltiazem; Dipeptides; Furosemide; Glomerular Filtration Rate; Hemodynamics; Humans; Lisinopril; Middle Aged; Prospective Studies; Renal Circulation | 1993 |
A diuretic is more effective than a beta-blocker in hypertensive patients not controlled on amlodipine and lisinopril.
Topics: Adrenergic beta-Antagonists; Adult; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atenolol; Bendroflumethiazide; Calcium Channel Blockers; Cross-Over Studies; Diuretics; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hypertension; Lisinopril; Male; Middle Aged; Sodium Chloride Symporter Inhibitors; Treatment Failure | 1996 |
Lisinopril reduces postexercise albuminuria more effectively than atenolol in primary hypertension.
Topics: Adrenergic beta-Antagonists; Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Atenolol; Cross-Over Studies; Double-Blind Method; Exercise; Female; Humans; Hypertension; Lisinopril; Male; Middle Aged | 1996 |
Comparison of different fixed antihypertensive combination drugs: a double-blind, placebo-controlled parallel group study.
Topics: Adult; Aged; Antihypertensive Agents; Atenolol; Blood Pressure; Chlorthalidone; Delayed-Action Preparations; Double-Blind Method; Drug Combinations; Drug Tolerance; Female; Humans; Hydrochlorothiazide; Hypertension; Indoles; Lisinopril; Male; Middle Aged; Safety; Verapamil | 1997 |
Long-term effect of lisinopril and atenolol on kidney function in hypertensive NIDDM subjects with diabetic nephropathy.
Topics: Aged; Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Atenolol; Blood Pressure; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Double-Blind Method; Follow-Up Studies; Glomerular Filtration Rate; Humans; Hypertension, Renal; Kidney; Lisinopril; Male; Middle Aged; Prospective Studies; Rabbits; Single-Blind Method; Time Factors | 1997 |
Lisinopril improves endothelial dysfunction in hypertensive NIDDM subjects with diabetic nephropathy.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atenolol; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Double-Blind Method; Endothelium, Vascular; Female; Humans; Hypertension; Lisinopril; Male; Middle Aged; Patient Compliance; Prospective Studies; Renin | 1997 |
Sexual function in hypertensive males treated with lisinopril or atenolol: a cross-over study.
Topics: Adult; Antihypertensive Agents; Atenolol; Cross-Over Studies; Double-Blind Method; Humans; Hypertension; Libido; Lisinopril; Male; Middle Aged; Sex Characteristics; Sexual Behavior | 1998 |
The impact of beta-receptor blocker addition to high-dose angiotensin-converting enzyme inhibitor-nitrate therapy in heart failure.
Topics: Adrenergic beta-Antagonists; Adult; Angiotensin-Converting Enzyme Inhibitors; Atenolol; Cohort Studies; Drug Therapy, Combination; Echocardiography, Doppler; Female; Heart Failure; Humans; Isosorbide Dinitrate; Lisinopril; Male; Middle Aged; Prospective Studies; Retrospective Studies; Treatment Outcome; Vasodilator Agents | 1998 |
Factors related to the occurrence of microalbuminuria during antihypertensive treatment in essential hypertension.
Topics: Adrenergic beta-Antagonists; Adult; Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atenolol; Bisoprolol; Calcium Channel Blockers; Enalapril; Female; Humans; Hypertension; Lisinopril; Male; Middle Aged; Nifedipine; Proportional Hazards Models; Regression Analysis; Risk Factors; Treatment Outcome | 2002 |
Role of diuretics in the prevention of heart failure: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atenolol; Calcium Channel Blockers; Chlorthalidone; Diuretics; Double-Blind Method; Doxazosin; Drug Therapy, Combination; Female; Heart Failure; Hospitalization; Humans; Hypertension; Incidence; Lisinopril; Male; Middle Aged; Myocardial Infarction; Proportional Hazards Models; Risk; Treatment Outcome | 2006 |
Blood pressure control in Hispanics in the antihypertensive and lipid-lowering treatment to prevent heart attack trial.
Topics: Aged; Amlodipine; Antihypertensive Agents; Atenolol; Black People; Blood Pressure; Canada; Chlorthalidone; Clonidine; Double-Blind Method; Doxazosin; Female; Heart Diseases; Hispanic or Latino; Humans; Hydralazine; Hypertension; Hypolipidemic Agents; Lisinopril; Male; Middle Aged; Puerto Rico; Reserpine; Treatment Outcome; United States; United States Virgin Islands; White People | 2007 |
[Correction of portal hypertension by beta-adrenoblockers (atenolol and metoprolol) and inhibitors of ACE (lisinopril and enalapril) in liver cirrhosis].
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Atenolol; Blood Pressure Monitoring, Ambulatory; Drug Administration Schedule; Enalapril; Female; Hemodynamics; Humans; Hypertension, Portal; Lisinopril; Liver; Liver Cirrhosis, Alcoholic; Male; Metoprolol; Middle Aged; Treatment Outcome | 2007 |
Cerebrovascular support for cognitive processing in hypertensive patients is altered by blood pressure treatment.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Analysis of Variance; Angiotensin-Converting Enzyme Inhibitors; Atenolol; Blood Pressure; Brachial Artery; Brain; Cerebrovascular Circulation; Cognition; Cognition Disorders; Female; Heart Rate; Humans; Hypertension; Lisinopril; Male; Memory; Middle Aged; Vasodilation | 2008 |
Brain imaging findings predict blood pressure response to pharmacological treatment.
Topics: Aging; Antihypertensive Agents; Atenolol; Blood Pressure; Brain; Cerebrovascular Circulation; Cognition Disorders; Female; Humans; Hypertension; Lisinopril; Magnetic Resonance Imaging; Male; Memory, Short-Term; Middle Aged; Neuropsychological Tests; Positron-Emission Tomography; Predictive Value of Tests; Regression Analysis | 2008 |
A 16-week, randomized, double-blind, placebo-controlled, crossover trial to quantify the combined effect of an angiotensin-converting enzyme inhibitor and a beta-blocker on blood pressure reduction.
Topics: Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Algorithms; Angiotensin-Converting Enzyme Inhibitors; Atenolol; Blood Pressure; Blood Pressure Determination; Cross-Over Studies; Double-Blind Method; Drug Synergism; Drug Therapy, Combination; Female; Humans; Hypertension; Lisinopril; Male; Middle Aged; Regression Analysis; Time Factors; Treatment Outcome | 2008 |
Brain function, cognition, and the blood pressure response to pharmacological treatment.
Topics: Antihypertensive Agents; Atenolol; Blood Pressure; Brain; Brain Mapping; Cerebrovascular Circulation; Cognition; Cognition Disorders; Female; Humans; Hypertension; Lisinopril; Magnetic Resonance Imaging; Male; Memory, Short-Term; Middle Aged; Neuropsychological Tests; Positron-Emission Tomography; Regional Blood Flow; Tomography, Emission-Computed | 2010 |
Oxidative stress-associated hypertension in surgically induced brain injury patients: effects of β-blocker and angiotensin-converting enzyme inhibitor.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Angiotensin-Converting Enzyme Inhibitors; Atenolol; Craniotomy; Double-Blind Method; Female; Humans; Hypertension; Lipid Peroxidation; Lisinopril; Male; Middle Aged; Nitric Oxide; Oxidative Stress; Protein Carbonylation; Supratentorial Neoplasms; Treatment Outcome; Young Adult | 2013 |
Effects of a fixed-dose combination strategy on adherence and risk factors in patients with or at high risk of CVD: the UMPIRE randomized clinical trial.
Topics: Aged; Anticholesteremic Agents; Antihypertensive Agents; Aspirin; Atenolol; Blood Pressure; Cardiovascular Diseases; Cholesterol, LDL; Drug Combinations; Female; Humans; Hydrochlorothiazide; Lisinopril; Male; Medication Adherence; Middle Aged; Platelet Aggregation Inhibitors; Risk Factors; Simvastatin; Treatment Outcome | 2013 |
Hypertension in hemodialysis patients treated with atenolol or lisinopril: a randomized controlled trial.
Topics: Adult; Aged; Antihypertensive Agents; Atenolol; Double-Blind Method; Early Termination of Clinical Trials; Female; Humans; Hypertension; Hypertrophy, Left Ventricular; Kidney Failure, Chronic; Lisinopril; Male; Middle Aged; Myocardial Infarction; Renal Dialysis; Treatment Failure | 2014 |
A pragmatic randomized trial of a polypill-based strategy to improve use of indicated preventive treatments in people at high cardiovascular disease risk.
Topics: Administration, Oral; Adrenergic beta-1 Receptor Antagonists; Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Aspirin; Atenolol; Australia; Biomarkers; Blood Pressure; Cardiovascular Diseases; Cholesterol; Drug Combinations; Drugs, Generic; Female; General Practice; Humans; Hydrochlorothiazide; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Hypertension; Lisinopril; Male; Middle Aged; Platelet Aggregation Inhibitors; Polypharmacy; Primary Prevention; Prospective Studies; Risk Factors; Simvastatin; Sodium Chloride Symporter Inhibitors; Tablets; Time Factors; Treatment Outcome | 2015 |
Effect of fixed dose combination treatment on adherence and risk factor control among patients at high risk of cardiovascular disease: randomised controlled trial in primary care.
Topics: Adolescent; Adult; Aged; Antihypertensive Agents; Atenolol; Blood Pressure; Cardiovascular Diseases; Cholesterol, LDL; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lisinopril; Male; Medication Adherence; Middle Aged; New Zealand; Primary Health Care; Regression Analysis; Risk Factors; Simvastatin; Young Adult | 2014 |
Effect of lisinopril and atenolol on aortic stiffness in patients on hemodialysis.
Topics: Adrenergic beta-1 Receptor Antagonists; Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atenolol; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Female; Humans; Indiana; Kidney Diseases; Lisinopril; Male; Middle Aged; Pulse Wave Analysis; Renal Dialysis; Time Factors; Treatment Outcome; Vascular Stiffness | 2015 |
Aortic Stiffness, Ambulatory Blood Pressure, and Predictors of Response to Antihypertensive Therapy in Hemodialysis.
Topics: Adult; Aged; Antihypertensive Agents; Aorta; Atenolol; Blood Pressure Monitoring, Ambulatory; Early Termination of Clinical Trials; Echocardiography, Doppler; Female; Humans; Hypertension; Hypertrophy, Left Ventricular; Kidney Failure, Chronic; Lisinopril; Male; Middle Aged; Pulse Wave Analysis; Renal Dialysis; Treatment Outcome; Vascular Stiffness | 2015 |
Treating hypertension in hemodialysis improves symptoms seemingly unrelated to volume excess.
Topics: Antihypertensive Agents; Atenolol; Blood Pressure; Blood Volume; Body Weight; Female; Humans; Hypertension; Kidney Failure, Chronic; Lisinopril; Male; Middle Aged; Renal Dialysis; Treatment Outcome | 2016 |
Impact of switching from different treatment regimens to a fixed-dose combination pill (polypill) in patients with cardiovascular disease or similarly high risk.
Topics: Administration, Oral; Aged; Antihypertensive Agents; Aspirin; Atenolol; Biomarkers; Blood Pressure; Cardiovascular Diseases; Cholesterol, LDL; Drug Combinations; Drug Substitution; Europe; Female; Humans; Hydrochlorothiazide; Hydroxymethylglutaryl-CoA Reductase Inhibitors; India; Lisinopril; Male; Medication Adherence; Middle Aged; Platelet Aggregation Inhibitors; Polypharmacy; Risk Assessment; Risk Factors; Simvastatin; Tablets; Time Factors; Treatment Outcome | 2017 |
32 other study(ies) available for atenolol and lisinopril
Article | Year |
---|---|
Interaction of digoxin with antihypertensive drugs via MDR1.
Topics: Animals; Antihypertensive Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Cells, Cultured; Digoxin; Drug Interactions; Humans; Time Factors | 2002 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
How well can the Caco-2/Madin-Darby canine kidney models predict effective human jejunal permeability?
Topics: Animals; Disease Models, Animal; Dogs; Humans; Jejunal Diseases; Kidney Diseases; Models, Biological; Permeability; Porosity; Regression Analysis | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Prediction of drug intestinal absorption by new linear and non-linear QSPR.
Topics: Humans; Intestinal Absorption; Linear Models; Molecular Conformation; Nonlinear Dynamics; Permeability; Pharmaceutical Preparations; Probability; Quantitative Structure-Activity Relationship; Thermodynamics | 2011 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Comparison of the cardiac and hemodynamic effects of lisinopril and atenolol in patients with hypertension: therapeutic implications.
Topics: Adult; Aged; Antihypertensive Agents; Atenolol; Blood Pressure; Cardiac Output; Dipeptides; Female; Heart Rate; Hemodynamics; Humans; Hypertension; Lisinopril; Male; Middle Aged; Vascular Resistance; Ventricular Function, Left | 1992 |
Comparison of antihypertensive therapies by noninvasive techniques.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Atenolol; Blood Pressure Determination; Echocardiography; Enalapril; Humans; Hypertension; Lisinopril; Male; Middle Aged; Monitoring, Physiologic; Time Factors | 1989 |
[Paroxysmal atrial fibrillation and flutter and "occult" arterial hypertension. The importance of the ambulatory monitoring of the blood pressure. Apropos 2 cases].
Topics: Atenolol; Atrial Fibrillation; Atrial Flutter; Blood Pressure Monitors; Diltiazem; Drug Therapy, Combination; Humans; Hypertension; Lisinopril; Male; Middle Aged; Verapamil | 1993 |
Ask the doctor. I take atenolol and lisinopril for my blood pressure. I have a blood pressure monitor that I use at home and I find that, on average, my pressure is 150/85 in the morning and 130/80 in the afternoon. Should I be worried about the high morn
Topics: Antihypertensive Agents; Atenolol; Blood Pressure; Humans; Hypertension; Lisinopril | 2000 |
[Medicamentous kidney protection in type 2 diabetic patients--is cheaper also more economical? A model calculation for Swiss health care].
Topics: Adult; Antihypertensive Agents; Atenolol; Cost Savings; Cost-Benefit Analysis; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Drug Costs; Female; Humans; Kidney Failure, Chronic; Kidney Function Tests; Lisinopril; Male; Middle Aged; Models, Economic; Switzerland; Verapamil | 2002 |
Differential effects of the angiotensin-converting enzyme inhibitor lisinopril versus the beta-adrenergic receptor blocker atenolol on hemodynamics and left ventricular contractile function in experimental mitral regurgitation.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Atenolol; Dogs; Hemodynamics; Lisinopril; Male; Mitral Valve Insufficiency; Myocardial Contraction; Ventricular Function, Left | 2002 |
Captopril inhibits glucose accumulation in retinal cells in diabetes.
Topics: Adrenergic beta-Antagonists; Aldehyde Reductase; Angiotensin-Converting Enzyme Inhibitors; Animals; Atenolol; Blood Glucose; Blotting, Western; Captopril; Cattle; Cells, Cultured; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Endothelium, Vascular; Glucose; Glucose Transporter Type 1; Lisinopril; Male; Monosaccharide Transport Proteins; Rats; Rats, Sprague-Dawley; Retina; Retinal Vessels | 2003 |
[Regulatory-adaptive abilities of hypertensive patients treated with lisinopril and atenolol].
Topics: Adaptation, Physiological; Adult; Aged; Antihypertensive Agents; Atenolol; Blood Pressure; Female; Humans; Hypertension; Lisinopril; Male; Middle Aged | 2005 |
Medication adherence before an increase in antihypertensive therapy: a cohort study using pharmacy claims data.
Topics: Adult; Aging; Antihypertensive Agents; Atenolol; Case-Control Studies; Cohort Studies; Drug Prescriptions; Female; Humans; Hydrochlorothiazide; Hypertension; Insurance Claim Review; Insurance, Pharmaceutical Services; Lisinopril; Male; Middle Aged; Patient Compliance; Prospective Studies; Time Factors | 2005 |
LC and LC-MS methods for the investigation of polypills for the treatment of cardiovascular diseases. Part 1. Separation of active components and classification of their interaction/degradation products.
Topics: Aspirin; Atenolol; Atorvastatin; Cardiovascular Agents; Chromatography, High Pressure Liquid; Drug Combinations; Drug Interactions; Drug Stability; Heptanoic Acids; Hydrochlorothiazide; Lisinopril; Pravastatin; Pyrroles; Simvastatin; Spectrometry, Mass, Electrospray Ionization | 2008 |
Polypill for the treatment of cardiovascular diseases part 2. LC-MS/TOF characterization of interaction/degradation products of atenolol/lisinopril and aspirin, and mechanisms of formation thereof.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Atenolol; Cardiovascular Agents; Chromatography, Liquid; Drug Combinations; Drug Interactions; Lisinopril; Mass Spectrometry; Molecular Structure; Molecular Weight; Platelet Aggregation Inhibitors | 2008 |
Cardiovascular protection by β-blockade in hypertensive haemodialysis patients: the Hypertension in Haemodialysis Patients Treated With Atenolol or Lisinopril (HDPAL) trial.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Atenolol; Cardiotonic Agents; Humans; Hypertension; Lisinopril; Randomized Controlled Trials as Topic; Renal Dialysis; Renal Insufficiency, Chronic | 2014 |
Massive Atenolol, Lisinopril, and Chlorthalidone Overdose Treated with Endoscopic Decontamination, Hemodialysis, Impella Percutaneous Left Ventricular Assist Device, and ECMO.
Topics: Adrenergic beta-1 Receptor Antagonists; Adult; Atenolol; Cardiovascular Agents; Chlorthalidone; Combined Modality Therapy; Decontamination; Drug Overdose; Emergency Service, Hospital; Endoscopy, Digestive System; Extracorporeal Membrane Oxygenation; Female; Humans; Lisinopril; Multiple Organ Failure; Renal Dialysis; Shock, Cardiogenic; Tablets; Transcutaneous Electric Nerve Stimulation; Treatment Outcome | 2015 |
Reducing arterial stiffness in CKD: revising the paradigms.
Topics: Adrenergic beta-1 Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atenolol; Female; Humans; Kidney Diseases; Lisinopril; Male; Renal Dialysis; Vascular Stiffness | 2015 |
Cardiovascular disease: Questioning the effect of β-blockers on vascular stiffness.
Topics: Adrenergic beta-1 Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atenolol; Female; Humans; Kidney Diseases; Lisinopril; Male; Renal Dialysis; Vascular Stiffness | 2015 |
Interaction of PEGylated anti-hypertensive drugs, amlodipine, atenolol and lisinopril with lipid bilayer membrane: A molecular dynamics simulation study.
Topics: Amlodipine; Antihypertensive Agents; Atenolol; Diffusion; Dimyristoylphosphatidylcholine; Energy Transfer; Hydrogen Bonding; Hydrophobic and Hydrophilic Interactions; Lipid Bilayers; Lisinopril; Molecular Dynamics Simulation; Molecular Structure; Polyethylene Glycols; Software; Static Electricity; Structure-Activity Relationship; Time Factors; Water | 2015 |
Combination of anti-hypertensive drugs: a molecular dynamics simulation study.
Topics: Amlodipine; Antihypertensive Agents; Atenolol; Dimyristoylphosphatidylcholine; Humans; Hydrogen Bonding; Hypertension; Lipid Bilayers; Lisinopril; Molecular Conformation; Molecular Dynamics Simulation; Software; Water | 2017 |
The effects of antihypertensive class on gout in older adults: secondary analysis of the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial.
Topics: Aged; Amlodipine; Antihypertensive Agents; Atenolol; Blood Pressure; Chlorthalidone; Female; Gout; Humans; Hypertension; Lisinopril; Male; Middle Aged; Myocardial Infarction; Treatment Outcome | 2020 |